Mr. Kimball B Forbes, MCD FAAA Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1490 E Foremaster Dr, Ste 360, St George, UT 84790 Phone: 435-688-8866 Fax: 435-688-2882 |
Dr. Steven Lewis, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 617 E Riverside Dr Ste 201, St George, UT 84790 Phone: 435-628-3334 Fax: 435-628-2137 |
Advanced Hearing And Balance Specialists Audiologist Medicare: Medicare Enrolled Practice Location: 617 E Riverside Dr Ste 102, St George, UT 84790 Phone: 435-688-8866 Fax: 435-688-2882 |
Cedar Hearing & Balance Center, Desert Valley Hearing & Balance Center Audiologist Medicare: Medicare Enrolled Practice Location: 1054 East Riverside Dr, Suite 201, St George, UT 84790 Phone: 435-688-8991 Fax: 435-688-2122 |
Ms. Paula Johnston, MA, CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 617 E Riverside Dr Ste 102, St George, UT 84790 Phone: 435-688-8866 Fax: 435-688-2882 |
Dr. Lance F Greer, AUD, FAAA Audiologist Medicare: Accepting Medicare Assignments Practice Location: 617 E Riverside Dr Ste 102, St George, UT 84790 Phone: 435-688-8866 Fax: 435-688-2882 |
News Archive
Chronic inflammation has been directly associated with heart disease and other physical ailments. But LSU graduate student Nathanial Gilbert and Professor of Biological Sciences Marcia Newcomer, together with Associate Professor Sue Bartlett, have developed the first 3-D model of Human 5-Lipoxygenase, or 5-LOX, the molecule responsible for creating inflammatory compounds that provoke asthma.
On Tuesday, President Obama pitched Democrats' health reform plans to senior citizens and assured them that Medicare benefits would not be cut to pay for covering the uninsured, the New York Times reports. Meanwhile, members of Congress said they were "deluged" with constituent calls expressing concern over the future of their Medicare coverage.
The efficacy of continuous UV-C disinfection robots versus pulsed xenon (PU-UX) was highlighted in a recently published study of ultraviolet (UV) light disinfection systems by an influential infection prevention research team, including Curtis Donskey, M.D.
Adaptimmune Therapeutics plc, a clinical stage biopharmaceutical company focused on the use of T-cell therapy to treat cancer, today announced that the U.S. Food and Drug Administration has accepted the Company's investigational new drug (IND) application for autologous genetically modified T-cells expressing enhanced T cell receptors specific for MAGE A10 (MAGE-A10 T) in patients with locally advanced or metastatic non-small cell lung cancer, and that the IND is now active.
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, today announced that patient enrollment was completed in March in its dermaPACEā¢ Phase III pivotal, randomized, double-blinded, sham controlled, multicenter clinical trial comparing its Pulsed Acoustic Cellular Expression technology, utilizing the dermaPACEā¢ tissue regeneration device, to sham control for the treatment of diabetic foot ulcers.
› Verified 2 days ago